{
    "clinical_study": {
        "@rank": "31593", 
        "acronym": "DDS-25", 
        "arm_group": {
            "arm_group_label": "DDS-25", 
            "arm_group_type": "Experimental", 
            "description": "Intravitreal injection of DDS-25(Dexamethasone drug delivery system )"
        }, 
        "brief_summary": {
            "textblock": "This study will evaluate the safety and efficacy of an intravitreal implant of dexamethasone\n      (DDS-25) for the treatment of macular edema associated with retinal vein occlusion."
        }, 
        "brief_title": "DDS-25 Gauge in Patients With Macular Edema Secondary to Retinal Vein Occlusion (RVO)", 
        "completion_date": {
            "#text": "July 2013", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Macular Edema", 
            "Retinal Vein Occlusion"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Edema", 
                "Macular Edema", 
                "Retinal Vein Occlusion"
            ]
        }, 
        "detailed_description": {
            "textblock": "Evaluate the effects on visual acuity, electroretinography, fluorescein angiography and\n      optical coherence tomography in 10 patients with macular edema associated with retinal vein\n      occlusion undergoing intravitreal injection of implant of dexamethasone (DDS-25)."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  18 years of age or older with macular edema resulting from retinal vein occlusion\n\n          -  Decrease in visual acuity in at least one eye as a result of macular edema (20/50 or\n             worse)\n\n          -  Visual acuity in other eye no worse than 20/200\n\n        Exclusion Criteria:\n\n          -  Known anticipated need for ocular surgery within next 12 months\n\n          -  History of glaucoma or current high eye pressure requiring more than 1 medication\n\n          -  Diabetic retinopathy\n\n          -  Uncontrolled systemic disease\n\n          -  Known steroid-responder\n\n          -  Use of systemic steroids\n\n          -  Use of warfarin/heparin"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 8, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01662518", 
            "org_study_id": "Bramets-01"
        }, 
        "intervention": {
            "arm_group_label": "DDS-25", 
            "description": "350 mg Dexamethasone posterior segment drug delivery system (DDS-25) injection into the vitreous cavity at baseline", 
            "intervention_name": "Dexamethasone drug delivery system (DDS-25)", 
            "intervention_type": "Device"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Dexamethasone acetate", 
                "Dexamethasone", 
                "Dexamethasone 21-phosphate", 
                "BB 1101"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "August 9, 2012", 
        "location": {
            "contact": {
                "email": "rubenssiqueira@terra.com.br", 
                "last_name": "Rubens C Siqueira, MD,PhD", 
                "phone": "55(17)32345858"
            }, 
            "facility": {
                "address": {
                    "city": "Sao Jose do Rio Preto", 
                    "country": "Brazil", 
                    "state": "SP", 
                    "zip": "15010-100"
                }, 
                "name": "Centro de Pesquisa Rubens Siqueira"
            }, 
            "investigator": {
                "last_name": "Rubens C Siqueira, MD,PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Safety and Efficacy Study to Assess DDS-25 Gauge in Patients With Macular Edema Secondary to Retinal Vein Occlusion (RVO)", 
        "overall_contact": {
            "email": "rubenssiqueira@terra.com.br", 
            "last_name": "Rubens C Siqueira, MD,PhD", 
            "phone": "55(17)32140896"
        }, 
        "overall_contact_backup": {
            "email": "rubenssiqueira@terra.com.br", 
            "last_name": "Rubens C Siqueira, MD,PhD", 
            "phone": "55(17)32345858"
        }, 
        "overall_official": {
            "affiliation": "Centro de Pesquisa Rubens Siqueira", 
            "last_name": "Rubens C Siqueira, MD,PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Brazil: National Committee of Ethics in Research", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_completion_date": {
            "#text": "December 2012", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Best Corrected Visual Acuity (BCVA)", 
            "safety_issue": "Yes", 
            "time_frame": "Day 0 - Day 180"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01662518"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Centro de Pesquisa Rubens Siqueira", 
            "investigator_full_name": "Rubens Camargo Siqueira", 
            "investigator_title": "MD,PhD - Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Change in central foveal thickness at 48 weeks", 
            "safety_issue": "Yes", 
            "time_frame": "1 day to 48 weeks"
        }, 
        "source": "Centro de Pesquisa Rubens Siqueira", 
        "sponsors": {
            "collaborator": {
                "agency": "University of Sao Paulo", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Centro de Pesquisa Rubens Siqueira", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2011", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2012"
    }
}